The obesity paradox in beyond total mesorectal excision surgery for locally advanced and recurrent rectal cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Surgery
Link
http://link.springer.com/article/10.1007/s13304-019-00631-6/fulltext.html
Reference61 articles.
1. Hong YS, Nam BH, Kim KP, Kim JE, Park SJ, Park YS et al (2014) Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial. Lancet Oncol. 15(11):1245–1253
2. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277–300
3. Mohan HM, Evans MD, Larkin JO, Beynon J, Winter DC (2013) Multivisceral resection in colorectal cancer: a systematic review. Ann Surg Oncol 20(9):2929–2936
4. Beyond TMEC (2013) Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 100(8):E1–E33
5. Faerden AE, Naimy N, Wiik P, Reiertsen O, Weyessa S, Tronnes S et al (2005) Total mesorectal excision for rectal cancer: difference in outcome for low and high rectal cancer. Dis Colon Rectum. 48(12):2224–2231
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Body mass index–based predictions and personalized clinical strategies for colorectal cancer in the context of PPPM;EPMA Journal;2022-12-02
2. A systematic review and meta-analysis assessing the impact of body mass index on long-term survival outcomes after surgery for colorectal cancer;European Journal of Cancer;2022-09
3. The impact of body mass index on prognosis in patients with colon carcinoma;International Journal of Colorectal Disease;2022-04-14
4. The obesity paradox in patients with colorectal cancer: a systematic review and meta-analysis;Nutrition Reviews;2022-02-19
5. Impact of body-mass index on treatment and outcome in locally advanced rectal cancer: A secondary, post-hoc analysis of the CAO/ARO/AIO-04 randomized phase III trial;Radiotherapy and Oncology;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3